Assistant Professor, Ophthalmology, Tufts Medical Center

Ophthalmology

Jeffrey S. Heier is an expert in the field of Ophthalmology. He went to medical school at Boston University School of Medicine. Boston University School of Medicine is ranked 30/52 in Research/PrimaryCare. He received 4 awards: "Regional Top Doctor", "Meaningful Use Stage 1 Certification", "Fellow (FAAO)" and "Super Doctor". Jeffrey Heier is a published MD. He has 23 publications published. The most current publication "Outcomes after Failed Pneumatic Retinopexy for Retinal Detachment." He accepts Medicare payments and is listed with Medicare.gov.

Publications

---

• Comparison of Aflibercept, Bevacizumab, and Ranibizumab for Treatment of Diabetic Macular Edema: Extrapolation of Data to Clinical Practice.
• Intravitreal Aflibercept for Macular Edema Following Branch Retinal Vein Occlusion: 52-Week Results of the VIBRANT Study.
• Microperimetric assessment of retinal sensitivity in eyes with diabetic Macular edema from a phase 2 study of intravitreal aflibercept.
• Treatment of Diabetic Macular Edema with an Inhibitor of Vascular Endothelial-Protein Tyrosine Phosphatase That Activates Tie2.
• Improvement in Vision-Related Function with Intravitreal Aflibercept: Data from Phase 3 Studies in Wet Age-Related Macular Degeneration.
• Intravitreal Aflibercept for Macular Edema Following Branch Retinal Vein Occlusion: The 24-Week Results of the VIBRANT Study.
• Intravitreal Aflibercept for Diabetic Macular Edema.
• Noninfectious Inflammation After Intravitreal Injection of Aflibercept: Clinical Characteristics and Visual Outcomes.
• Endoscopic vitrectomy.
• Intravitreal Aflibercept Injection for Macular Edema Due to Central Retinal Vein Occlusion: Two-Year Results from the COPERNICUS Study.
• Initial utilization of aflibercept in exudative age-related Macular degeneration.
• Expanded criteria for pneumatic retinopexy and potential cost savings.
• Intravitreal Aflibercept Injection for Neovascular Age-related Macular Degeneration: Ninety-Six-Week Results of the VIEW Studies.
• Long-term Outcomes in Patients with Retinal Vein Occlusion Treated with Ranibizumab: The RETAIN Study.
• OCT-BASED INTERPRETATION OF THE VITREOMacular INTERFACE AND INDICATIONS FOR PHARMACOLOGIC VITREOLYSIS.
• Putting theories and results into practice: managing cases.
• Neovascular age-related Macular degeneration: individualizing therapy in the era of anti-angiogenic treatments.
• Treatment of Diabetic Macular Edema With a Designed Ankyrin Repeat Protein That Binds Vascular Endothelial Growth Factor: A Phase I/II Study.
• Intravitreal aflibercept injection for Macular edema secondary to central retinal vein occlusion: 1-year results from the phase 3 COPERNICUS study.
• Twelve-Month Efficacy and Safety of 0.5 mg or 2.0 mg Ranibizumab in Patients with Subfoveal Neovascular Age-Related Macular Degeneration.
• Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration.
• Outcomes after Failed Pneumatic Retinopexy for Retinal Detachment.

Schools

---

• Boston University School Of Medicine

• Fitzsimons Amc Co

• Ophthalmic Consult Of Boston

Procedures Preformed

---

• Cataract Removal Surgery
• Repair of Retinal Detachment or Retinal Tear
• Vitrectomy (incl. Macular Hole Repair)

Conditions Treated

---

• Acute Endophthalmitis
• Age-Related Macular Degeneration
• Aphakia and Other Disorders of Lens
• Benign Neoplasm of Choroid
• View All

Doctors Specialties

---

• Ophthalmology

Accepted Insurances

---

Awards

---

• Regional Top Doctor
• Meaningful Use Stage 1 Certification
• Fellow (FAAO)
• Super Doctor

Education

---

• Boston University School of Medicine

Hospital

---

• Massachusetts Eye and Ear Infirmary
• Massachusetts General Hospital

Drug Facts

---

NPI NUMBER		1578546917
NPPES Provider LastName		HEIER
NPPES Provider FirstName		JEFFREY
NPPES Provider ZIPCode		021142517
NPPES Provider State		MA
Specialty Description		Ophthalmology
Total Claim Count		312.0
Distinct Opioid Count		0.0
Opioid Claim Count		0.0
Percent Opioid Claims		0.0

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1578546917
Last Name Of The Provider	HEIER
First Name Of The Provider	JEFFREY
View All

Similar Doctors

---

	Dr. Joan W. Miller, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Suzanne C. Johnston, MD
	Dr. Xiang Q. Werdich, MD This Doctor is OpenDoctor Recommended.
	Dr. Zhonghui Luo, MD This Doctor is OpenDoctor Recommended.
	Dr. Brian P. Hafler, MD This Doctor is OpenDoctor Recommended.
	Dr. Hasanain T. Shikari, MD This Doctor is OpenDoctor Recommended.
	Dr. Lloyd P. Aiello, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Lucy H. Young, MD This Doctor is OpenDoctor Recommended.
	Dr. Nancy Kim, MD This Doctor is OpenDoctor Recommended.
	Dr. John I. Loewenstein, MD This Doctor is OpenDoctor Recommended.
	Dr. Archana T. Seethala, MD This Doctor is OpenDoctor Recommended.
	Dr. Abumere F. Akinwale, MD This Doctor is OpenDoctor Recommended.
	Dr. Johanna M. Seddon, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Catherine A. Cox, MD
	Dr. Thomas Kandl, MD This Doctor is OpenDoctor Recommended.

---

Doctor Directory | TOS | twitter | FB | Angel | blog